Spironolactone Tablet
Product Images NDC 53746-511

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Spironolactone (NDC 53746-511). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Amneal Pharmaceuticals Of New York Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

20 (Spironolactone Tablets Usp 1)

FDA Label Image

10 (Spironolactone Tablets Usp 2)

10 (Spironolactone Tablets Usp 2)
The text provides a comparison between two groups of data, Spironolactone (n=822) and Piaceto (n=841) with a significant difference based on the Log-rank p-value (<0.001). The last line appears to show some kind of numerical values, but they are not recognizable as text, and therefore their meaning is not available.*
FDA Label Image

2 (Spironolactone Tablets Usp 3)

FDA Label Image

1 (Spironolactone Tablets Usp 4)

1 (Spironolactone Tablets Usp 4)
The text describes information about NDC 53746-511-30 Spironolactone Tablets, USP that are prescribed typically for adults. Each table contains Spironolactone, USP. The package contains 30 tablets and should be kept in a room temperature-controlled environment. The manufacturer of these tablets is Amneal Pharmaceuticals Pvt. Ltd in Ahmedabad, India, and distributed by Amneal Pharmaceuticals LLC in Bridgewater, NJ. A manufacturing license number G/25/1941 is mentioned. The prescription is available only through a doctor's prescription, and the instructions for the drug dosage can be found in the literature attached to it. The text also mentions a non-varnish area for printing lot and expiry date.*
FDA Label Image

7 (Spironolactone Tablets Usp 5)

7 (Spironolactone Tablets Usp 5)
NDC 53746-514-30 is a medication called Spironolactone which is available in the form of tablets. Each tablet contains 50mg of Spironolactone, and the usual adult dosage can be found in the attached literature. It is recommended to store the medication in a tight, light-resistant container at 20° to 25°C (68" to 77°F) [see USP Controlled Room Temperature]. The manufacturer of the medication is Amneal Pharmaceuticals Pvt. Ltd., Ahmedabad 382220, INDIA and it is distributed by Amneal Pharmaceuticals LLC, Bridgewater, NJ 08807.*
FDA Label Image

13 (Spironolactone Tablets Usp 6)

13 (Spironolactone Tablets Usp 6)
This is a medication containing Spironolactone as its active ingredient. The usual adult dosage is not mentioned in the given text and is rather referenced in the attached literature. It should be stored between 20° to 25°C (68" to 77°F) in a tight and light-resistant container. The manufacturer is Amneal Pharmaceuticals Pvt. Lid., based in Ahmedabad, India, and the product is distributed by Amneal Pharmaceuticals LLC in Bridgewater, NJ. Other information including NDC number, manufacturing license number, and revised date is also provided.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.